Due to the rapid emergence of antibiotic-resistant bacteria, there is a growing need to discover
new antibiotics. To address this challenge, we trained a deep neural network capable of …

Acinetobacter baumannii is a nosocomial Gram-negative pathogen that often displays
multidrug resistance. Discovering new antibiotics against A. baumannii has proven challenging …

Although metabolism plays an active role in antibiotic lethality, antibiotic resistance is generally
associated with drug target modification, enzymatic inactivation, and/or transport rather …

Effective treatments for COVID-19 are urgently needed. However, discovering single-agent
therapies with activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2…

Background An ageing population with multimorbidity is putting pressure on health systems.
A popular method of managing this pressure is identification of patients in primary care ‘at-…

The increasing use of polymyxins 1 in addition to the dissemination of plasmid-borne colistin
resistance threatens to cause a serious breach in our last line of defence against multidrug-…

Antibiotics target energy-consuming processes. As such, perturbations to bacterial metabolic
homeostasis are significant consequences of treatment. Here, we describe three postulates …

Bactericidal antibiotics kill bacteria by perturbing various cellular targets and processes.
Disruption of the primary antibiotic-binding partner induces a cascade of molecular events, …

The discovery of novel structural classes of antibiotics is urgently needed to address the
ongoing antibiotic resistance crisis 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 – 9 . Deep learning approaches have …

The rise of pan-resistant bacteria is creating an urgent need for structurally novel antibiotics.
Artificial intelligence methods can discover new antibiotics, but existing methods have …